CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −838 | $65.72 | $55K | 104,778 |
| 2025-10-03 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −877 | $66.67 | $58K | 103,901 |
| 2025-10-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,124 | 18,126 | ||
| 2025-10-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,266 | 15,860 | ||
| 2025-10-03 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,265 | 13,595 | ||
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +3,442 | $30.86 | $106K | 104,067 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −1,609 | $65.46 | $105K | 102,458 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −1,760 | $66.56 | $117K | 100,698 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −73 | $67.16 | $5K | 100,625 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise 10b5-1 | +51,558 | $30.86 | $1.6M | 152,183 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −23,419 | $65.45 | $1.5M | 128,764 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −23,863 | $66.45 | $1.6M | 104,901 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −4,276 | $67.15 | $287K | 100,625 |
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,442 | 51,558 | ||
| 2025-10-03 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −51,558 | 0 | ||
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +22,661 | $38.10 | $863K | 126,562 |
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −22,117 | $61.33 | $1.4M | 104,445 |
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −544 | $62.09 | $34K | 103,901 |
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise 10b5-1 | +1,019 | $38.10 | $39K | 104,920 |
| 2025-09-12 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −1,019 | $61.31 | $62K | 103,901 |
Page 22 of 25 · 493 trades